MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 2.8500
- +0.0100+0.35%
Close Dec 20 16:00 ET
- 2.9500
- +0.1000+3.51%
Post 20:01 ET
192.62MMarket Cap-1.91P/E (TTM)
2.9600High2.8000Low2.86MVolume2.8100Open2.8400Pre Close8.19MTurnover6.43%Turnover RatioLossP/E (Static)67.59MShares19.050052wk High0.59P/B126.84MFloat Cap2.700052wk Low--Dividend TTM44.51MShs Float85.0000Historical High--Div YieldTTM5.63%Amplitude0.0300Historical Low2.8590Avg Price1Lot Size
Perspective Therapeutics Key Stats
EPS
According to the latest financial report of Perspective Therapeutics, the latest earnings per share (TTM) for the company is -0.21. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Perspective Therapeutics's free cash flow? The latest report shows it as -26.35M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Perspective Therapeutics shows that the company's current ratio is 9.60, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Perspective Therapeutics, the quick ratio is 9.53, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Perspective Therapeutics? The latest ROE figure is -4.52%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Perspective Therapeutics, the total asset return on investment (ROA) is -3.89%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Perspective Therapeutics's latest financial report to see how their gross margin is doing - currently at 36.97%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Perspective Therapeutics, the net profit margin is -3.78K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.